Target intelligence / Profile preview

Ganglioside GD3 (None)

Target
None
Molecular classification
Glycosphingolipid, Ganglioside
01

Overview

Ganglioside GD3 is a disialoganglioside involved in various cellular processes, including neurogenesis, apoptosis, and autophagy. It is overexpressed in several cancers, making it a potential target for immunotherapy. GD3 is synthesized from GM3 by GD3 synthase (ST8Sia I) and is found in high concentrations in developing brain tissue and some tumors.

02

Mechanism of action

GD3 serves as a target for cancer immunotherapy strategies due to its tumor-associated expression patterns. It modulates EGFR signaling and influences apoptosis and autophagy pathways.

03

Biological functions

NeurogenesisApoptosis regulationAutophagy modulationEGF receptor (EGFR) signaling
04

Disease associations

Cancer
05

Safety considerations

Potential for off-target effects in normal tissues expressing GD3Immune-related adverse events associated with immunotherapy targeting GD3
06

Biomarkers

Elevated GD3 levels in melanomaElevated GD3 levels in neuroblastomaElevated GD3 levels in gliomas

Beyond the preview

Go deeper on Ganglioside GD3 (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ganglioside GD3 (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call